等了19年!中国“小核酸第一股”上市,科学家创业有多难?

财能圈
Jan 09

长达十九年的漫长等待,换来港交所一记钟声——中国小核酸药物终于迎来首个上市公司,但这漫长的上市路,折射出中国原创新药研发的残酷现实。瑞博生物今日在港交所正式挂牌,成为中国小核酸药物领域第一股。发行价每股57.97港元,开盘大涨29%,市值突破120亿港元,成为2026年港股首个创新药IPO。这看似光鲜的上市时刻背后,是从2007年公司成立至今的十九年长跑。投资方磐霖资本自A轮起连续六轮投资,陪伴...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10